Concepedia

Alexander Biederstädt

AB

Statistics

Publications

8

Citations

517

H-Index

8

Active since

2020

Affiliations

Technical University of Munich(Current)

The University of Texas MD Anderson Cancer Center

The University of Texas Health Science Center at Houston

Heidelberg University

Goethe University Frankfurt

Alexander Biederstädt is an author at Technical University of Munich specializing in oncology, natural killer cell function, and immunotherapy.

ORCID

Publications per year

2020–2025

8

Publications

8

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape

Ye Li, Rafet Başar, Guohui Wang et al. · Nature Medicine · 2022 · 168 citations · Full text

, , +16

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype

Alexander Biederstädt, Zonera Hassan, Christian Schneeweis et al. · Gut · 2020 · 101 citations · Full text

, , +17

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

Sylvie Lorenzen, Alexander Biederstädt, Ulrich Ronellenfitsch et al. · BMC Cancer · 2020 · 52 citations · Full text

, , +16

CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis

Sunil Acharya, Rafet Başar, May Daher et al. · Cancer Discovery · 2024 · 52 citations · Full text

, , +17

How I treat high-risk acute myeloid leukemia using preemptive adoptive cellular immunotherapy

Alexander Biederstädt, Katayoun Rezvani · Blood · 2022 · 42 citations · Full text

, , +14

1–5 of 8